Also known as: Osh's Not-for-Profit Pharmaceuticals, Osh's Affordable Pharmaceuticals
Making low cost versions of high cost generic drugs.
Company is active
Event Year: 2018
Company is active
Event Year: 2018
Mark Cuban Cost Plus Drug Company, PBC, established with the mission of producing affordable alternatives to expensive generic medications, operates within the healthcare sector. By directly manufacturing or sourcing drugs and bypassing traditional pharmaceutical industry markups, the company aims to provide transparent and significantly lower prices to consumers. This initiative addresses the critical issue of medication affordability, striving to make essential treatments accessible to a broader population. The company's approach challenges conventional pricing models and seeks to disrupt the pharmaceutical landscape by prioritizing cost transparency and patient welfare.
Mark Cuban Cost Plus Drug Company, PBC, established with the mission of producing affordable alternatives to expensive generic medications, operates within the healthcare sector. By directly manufacturing or sourcing drugs and bypassing traditional pharmaceutical industry markups, the company aims to provide transparent and significantly lower prices to consumers. This initiative addresses the critical issue of medication affordability, striving to make essential treatments accessible to a broader population. The company's approach challenges conventional pricing models and seeks to disrupt the pharmaceutical landscape by prioritizing cost transparency and patient welfare.
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2018
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2018
Healthcare
Healthcare
Healthcare -> Consumer Health and Wellness
Healthcare -> Consumer Health and Wellness
Team size: 0
Hiring: No
Team size: 0
Hiring: No